Phase 2 Bladder Cancer Trial, Recruiting (NCT06696742)

Phase 2 Bladder Cancer Trial, Recruiting NCT06696742 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06696742 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

(For pre-surgery treatment) You have bladder cancer at a certain stage (T2 to T4a) that has not spread to nearby lymph nodes or other parts of the body
(For post-surgery treatment) After surgery, your cancer was found to have reached a more advanced stage (T3 or T4) and/or had spread to nearby lymph nodes

Who may not be able to join:

The trial doctors have assessed that you are not well enough to safely undergo major bladder removal surgery
You have previously had chemotherapy or immunotherapy treatment (given throughout the body, not just locally)
You have an active autoimmune disease that currently requires treatment, or another condition that requires long-term use of high doses of steroids or other medications that suppress the immune system
You have had a major surgery or serious physical injury within the last 28 days
You have received a live vaccine (such as certain flu or shingles vaccines) within the last 28 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06696742

Sponsor: The First Affiliated Hospital with Nanjing Medical University

Phase: Phase 2

Status: Recruiting

Condition: Bladder Cancer

More information: https://clinicaltrials.gov/study/NCT06696742

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

(For pre-surgery treatment) You have bladder cancer at a certain stage (T2 to T4a) that has not spread to nearby lymph nodes or other parts of the body
(For post-surgery treatment) After surgery, your cancer was found to have reached a more advanced stage (T3 or T4) and/or had spread to nearby lymph nodes

Who may not be able to join:

The trial doctors have assessed that you are not well enough to safely undergo major bladder removal surgery
You have previously had chemotherapy or immunotherapy treatment (given throughout the body, not just locally)
You have an active autoimmune disease that currently requires treatment, or another condition that requires long-term use of high doses of steroids or other medications that suppress the immune system
You have had a major surgery or serious physical injury within the last 28 days
You have received a live vaccine (such as certain flu or shingles vaccines) within the last 28 days

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Registry

ClinicalTrials.gov

Start date

1 February 2024

Est. completion

1 February 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov